Targeted next-generation sequencing to diagnose disorders of HDL cholesterol
A low level of HDL cholesterol (HDL-C) is a common clinical scenario and an important marker for increased cardiovascular risk. Many patients with very low or very high HDL-C have a rare mutation in one of several genes, but identification of the molecular abnormality in patients with extreme HDL-C...
Main Authors: | Singh N. Sadananda, Jia Nee Foo, Meng Tiak Toh, Lubomira Cermakova, Laia Trigueros-Motos, Teddy Chan, Herty Liany, Jennifer A. Collins, Sima Gerami, Roshni R. Singaraja, Michael R. Hayden, Gordon A. Francis, Jiri Frohlich, Chiea Chuen Khor, Liam R. Brunham |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-10-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520309743 |
Similar Items
-
ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL
by: Ashley M. Vaughan, et al.
Published: (2006-11-01) -
Serum amyloid A is not incorporated into HDL during HDL biogenesis[S]
by: Ailing Ji, et al.
Published: (2020-03-01) -
Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity
by: Eric T. Alexander, et al.
Published: (2013-12-01) -
Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI
by: Ailing Ji, et al.
Published: (2012-03-01) -
Nascent HDL formation by hepatocytes is reduced by the concerted action of serum amyloid A and endothelial lipase
by: Joanne M. Wroblewski, et al.
Published: (2011-12-01)